Last reviewed · How we verify
Arm 2 boosted protease inhibitors and maraviroc
Arm 2 boosted protease inhibitors and maraviroc is a Small molecule drug developed by Kirby Institute. It is currently FDA-approved. Also known as: maraviroc, atazanavir, lopinavir, darunavir.
At a glance
| Generic name | Arm 2 boosted protease inhibitors and maraviroc |
|---|---|
| Also known as | maraviroc, atazanavir, lopinavir, darunavir, fosamprenavir |
| Sponsor | Kirby Institute |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- MARCH Central Nervous System Substudy
- MARCH Renal Substudy (PHASE4)
- Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Arm 2 boosted protease inhibitors and maraviroc CI brief — competitive landscape report
- Arm 2 boosted protease inhibitors and maraviroc updates RSS · CI watch RSS
- Kirby Institute portfolio CI
Frequently asked questions about Arm 2 boosted protease inhibitors and maraviroc
What is Arm 2 boosted protease inhibitors and maraviroc?
Arm 2 boosted protease inhibitors and maraviroc is a Small molecule drug developed by Kirby Institute.
Who makes Arm 2 boosted protease inhibitors and maraviroc?
Arm 2 boosted protease inhibitors and maraviroc is developed and marketed by Kirby Institute (see full Kirby Institute pipeline at /company/kirby-institute).
Is Arm 2 boosted protease inhibitors and maraviroc also known as anything else?
Arm 2 boosted protease inhibitors and maraviroc is also known as maraviroc, atazanavir, lopinavir, darunavir, fosamprenavir.
What development phase is Arm 2 boosted protease inhibitors and maraviroc in?
Arm 2 boosted protease inhibitors and maraviroc is FDA-approved (marketed).
Related
- Manufacturer: Kirby Institute — full pipeline
- Also known as: maraviroc, atazanavir, lopinavir, darunavir, fosamprenavir
- Compare: Arm 2 boosted protease inhibitors and maraviroc vs similar drugs
- Pricing: Arm 2 boosted protease inhibitors and maraviroc cost, discount & access